数据链接：
官方服务：
资源简介：
Summary of findings (inactivated vaccines).
应用场景：
创建时间：
2022-01-21
相关数据集
The effectiveness of vaccination with Pandemrix in 2009–10 and/or trivalent influenza vaccine (TIV) in 2010–11 in preventing A(H1N1)pdm09 influenza infection during the epidemic season 2010–11.
Profile likelihood method was used for estimating the 95% confidence intervals (95%CI) for the vaccine effectiveness. 1Adjusted for the age group (18–49, 50–75 years), gender, underlying medical condi
NIAID Data Ecosystem50
DataSheet_1_Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.docx
BackgroundUnderstanding the long-term kinetic characteristics of SARS-CoV-2 antibodies and the impact of inactivated vaccines on SARS-CoV-2 antibodies in convalescent patients can provide information
NIAID Data Ecosystem40
Data for: Quantitative Efficacy Paradigms of the Influenza Clinical Drug Candidate EIDD-2801 in the Ferret Model
Numerical raw data and immunohistochemistry slide scans.
NIAID Data Ecosystem40
Background data of participants included in the analysis during the epidemic season 2010–11, according to vaccination with Pandemrix in 2009–10 and/or trivalent influenza vaccine (TIV) in 2010–11.
The vaccination status was determined with information given by the study participants during the two study phases 2009–11 and with information from the medical records of the health center of Tampere
NIAID Data Ecosystem40
Rate of pandemic (H1N1) influenza vaccination coverage among study population.
aχ2 test. bFischer's exact test. cThirty-two missing values were excluded from the analysis. dOne hundred and ninety-eight missing values were excluded from the analysis. eExchange rate based on two m
NIAID Data Ecosystem40
